Clearmind Medicine (CMND) Other Operating Expenses (2022 - 2024)
Clearmind Medicine (CMND) posted quarterly Other Operating Expenses of -$16498.0 for Q3 2024, down 107.68% quarter-over-quarter from $214732.0 in Q1 2024.
Clearmind Medicine (CMND) Other Operating Expenses (2022 - 2024) Analysis & Trends
Clearmind Medicine's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$16498.0 for Q3 2024.
- In Q3 2024, Other Operating Expenses changed N/A year-over-year to -$16498.0; the TTM figure through Apr 2025 stood at -$16498.0 (down 107.76% YoY), while the FY2022 annual figure was -$80209.0, down 84.95% from the prior year.
- Other Operating Expenses for Q3 2024 stood at -$16498.0, down from $214732.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $214732.0 in Q1 2024, with the low at -$16498.0 in Q3 2024.
- The 3-year median for Other Operating Expenses is -$1019.0 (2022), against an average of $49049.0.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | -16,498.00 |
| Jan 31, 2024 | 214,732.00 |
| Oct 31, 2023 | -2,038.00 |
| Apr 30, 2022 | 0.00 |